FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for amlodipine besylate, enabling the marketing of a generic version of the antihypertensive/antianginal medication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stable Angina Pectoris
• Vasospastic Angina

Drugs mentioned

• Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)